Perkins Coie Trust Company’s Gilead Sciences GILD Stock Holding History

Perkins Coie Trust Company’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,880	Closed	-$430K	–	310
2025 Q2	$430K	Hold	3,880	–	–	0.07%	84
2025 Q1	$435K	Buy	3,880 +100	+3%	+$10.3K	0.1%	81
2024 Q4	$349K	Hold	3,780	–	–	0.08%	87
2024 Q3	$317K	Hold	3,780	–	–	0.07%	88
2024 Q2	$259K	Hold	3,780	–	–	0.06%	91
2024 Q1	$277K	Sell	3,780 -25	-0.7%	-$1.92K	0.06%	89
2023 Q4	$308K	Sell	3,805 -62	-2%	-$4.83K	0.08%	84
2023 Q3	$290K	Buy	3,867 +3,820	+8,128%	+$294K	0.08%	83
2023 Q2	$3.62K	Sell	47 -34	-42%	-$2.71K	﹤0.01%	205
2023 Q1	$6.72K	Hold	81	–	–	﹤0.01%	204
2022 Q4	$6.95K	Hold	81	–	–	﹤0.01%	194
2022 Q3	$5K	Hold	81	–	–	﹤0.01%	207
2022 Q2	$5K	Hold	81	–	–	﹤0.01%	207
2022 Q1	$5K	Hold	81	–	–	﹤0.01%	212
2021 Q4	$6K	Hold	81	–	–	﹤0.01%	205
2021 Q3	$6K	Hold	81	–	–	﹤0.01%	219
2021 Q2	$6K	Hold	81	–	–	﹤0.01%	233
2021 Q1	$5K	Hold	81	–	–	﹤0.01%	213
2020 Q4	$5K	Sell	81 -47	-37%	-$2.84K	﹤0.01%	225
2020 Q3	$8K	Sell	128 -152	-54%	-$10.5K	﹤0.01%	207
2020 Q2	$22K	Hold	280	–	–	0.01%	186
2020 Q1	$21K	Sell	280 -60	-18%	-$4.15K	0.01%	197
2019 Q4	$22K	Sell	340 -200	-37%	-$13K	0.01%	221
2019 Q3	$34K	Hold	540	–	–	0.02%	198
2019 Q2	$36K	Hold	540	–	–	0.02%	188
2019 Q1	$35K	Hold	540	–	–	0.02%	187
2018 Q4	$34K	Hold	540	–	–	0.02%	184
2018 Q3	$42K	Hold	540	–	–	0.02%	186
2018 Q2	$38K	Hold	540	–	–	0.02%	190
2018 Q1	$41K	Sell	540 -16	-3%	-$1.27K	0.02%	182
2017 Q4	$40K	Sell	556 -142	-20%	-$10.8K	0.02%	187
2017 Q3	$57K	Hold	698	–	–	0.03%	156
2017 Q2	$49K	Hold	698	–	–	0.03%	173
2017 Q1	$47K	Hold	698	–	–	0.03%	158
2016 Q4	$50K	Buy	698 +298	+75%	+$22.1K	0.03%	151
2016 Q3	$32K	Hold	400	–	–	0.02%	165
2016 Q2	$33K	Hold	400	–	–	0.02%	163
2016 Q1	$37K	Buy	400 +200	+100%	+$18K	0.03%	150
2015 Q4	$20K	Hold	200	–	–	0.02%	173
2015 Q3	$20K	Hold	200	–	–	0.02%	175
2015 Q2	$23K	Hold	200	–	–	0.02%	177
2015 Q1	$20K	Hold	200	–	–	0.02%	181
2014 Q4	$19K	Hold	200	–	–	0.02%	171
2014 Q3	$21K	Hold	200	–	–	0.02%	167
2014 Q2	$17K	Hold	200	–	–	0.02%	160
2014 Q1	$14K	Hold	200	–	–	0.01%	169
2013 Q4	$15K	Buy	+200	New	+$13.9K	0.01%	157

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Perkins Coie Trust Company's GILD Position: Q3 2025 in Review

Perkins Coie Trust Company sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 3,880 shares — an estimated $430K sold.

Perkins Coie Trust Company first reported a position in GILD in Q4 2013 and held it in 47 quarters. The position peaked at $435K in Q1 2025. 2,027 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

Perkins Coie Trust Company reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
Perkins Coie Trust Company sold 3,880 Gilead Sciences shares in Q3 2025, an estimated $430K.
Perkins Coie Trust Company first reported a position in Gilead Sciences in Q4 2013 and held it in 47 quarters.
Perkins Coie Trust Company's Gilead Sciences position peaked at $435K in Q1 2025.
2,027 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Perkins Coie Trust Company's 13F filing for Q3 2025, filed 9 Oct 2025.